Local Institution - 012-942-F

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Running trials

• Active, not recruiting

  Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

  NCT04685135· Phase 3· Mirati Therapeutics Inc.· Source